PharmacyCodes



Zopiclonum [Inn-Latin] en es it fr

Zopiclonum [Inn-Latin] Brand names, Zopiclonum [Inn-Latin] Analogs

Zopiclonum [Inn-Latin] Brand Names Mixture

  • No information avaliable

Zopiclonum [Inn-Latin] Chemical_Formula

C17H17ClN6O3

Zopiclonum [Inn-Latin] RX_link

No information avaliable

Zopiclonum [Inn-Latin] fda sheet

Zopiclonum [Inn-Latin] msds (material safety sheet)

Zopiclonum [Inn-Latin] Synthesis Reference

No information avaliable

Zopiclonum [Inn-Latin] Molecular Weight

388.808 g/mol

Zopiclonum [Inn-Latin] Melting Point

178 oC

Zopiclonum [Inn-Latin] H2O Solubility

No information avaliable

Zopiclonum [Inn-Latin] State

Solid

Zopiclonum [Inn-Latin] LogP

-0.88

Zopiclonum [Inn-Latin] Dosage Forms

Tablet

Zopiclonum [Inn-Latin] Indication

For the short-term treatment of insomnia.

Zopiclonum [Inn-Latin] Pharmacology

Zopiclone is a nonbenzodiazepine hypnotic from the pyrazolopyrimidine class and is indicated for the short-term treatment of insomnia. While Zopiclone is a hypnotic agent with a chemical structure unrelated to benzodiazepines, barbiturates, or other drugs with known hypnotic properties, it interacts with the gamma-aminobutyric acid-benzodiazepine (GABABZ) receptor complex. Subunit modulation of the GABABZ receptor chloride channel macromolecular complex is hypothesized to be responsible for some of the pharmacological properties of benzodiazepines, which include sedative, anxiolytic, muscle relaxant, and anticonvulsive effects in animal models. Zopiclone binds selectively to the brain alpha subunit of the GABA A omega-1 receptor.

Zopiclonum [Inn-Latin] Absorption

No information avaliable

Zopiclonum [Inn-Latin] side effects and Toxicity

No information avaliable

Zopiclonum [Inn-Latin] Patient Information

No information avaliable

Zopiclonum [Inn-Latin] Organisms Affected

Humans and other mammals